← Leaderboards
Xuming Zhang
University Of Arkansas Med Scis Ltl Rock
$6,363,686
Attributed
$6,363,686
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–08$2M$1.5M$1M$500K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$6,363,686 · 5
By mechanism
U01$3,699,069 · 1
R01$1,892,908 · 2
R21$568,000 · 1
U54$203,709 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Wayne L Gray$1,666,793
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CulturePolymerase Chain ReactionYeast Two Hybrid SystemHost Organism InteractionMurine Hepatitis VirusDna Directed Rna PolymeraseRna BiosynthesisVaccine DevelopmentNucleocapsidLaboratory RabbitGenetic TranscriptionRna Binding ProteinProtein Protein InteractionSevere Acute Respiratory SyndromeGenetic Regulatory ElementVirus RnaRibonucleoproteinsRecombinantsPathogenesisMolecularHuman CoronavirusCoronavirus (Genus)GeneticAnimals
Grant awards (16)
Developing recombinant coronavirus vaccines for SARS$339,698
U01 · FY2008 · AI · contact PI
Development of Recombinant Pandemic Influenza Vaccines$203,709
U54 · FY2008 · AI · contact PI
Developing recombinant coronavirus vaccines for SARS$1,307,219
U01 · FY2007 · AI · contact PI
Demyelinating Disease-Viral and Cellular Function$185,710
R01 · FY2007 · NS · contact PI
Developing recombinant coronavirus vaccines for SARS$792,026
U01 · FY2006 · AI · contact PI
Demyelinating Disease-Viral and Cellular Function$191,257
R01 · FY2006 · NS · contact PI
Developing recombinant coronavirus vaccines for SARS$742,409
U01 · FY2005 · AI
Developing a recombinanat vacine for SARS$284,000
R21 · FY2005 · AI
Demyelinating Disease-Viral and Cellular Function$195,860
R01 · FY2005 · NS
Developing recombinant coronavirus vaccines for SARS$517,717
U01 · FY2004 · AI
Developing a recombinanat vaccine for SARS$284,000
R21 · FY2004 · AI
Demyelinating Disease-Viral and Cellular Function$195,860
R01 · FY2004 · NS
CORONAVIRUS RNA TRANSCRIPTION--VIRUS-HOST INTERACTION$449,060
R01 · FY2003 · AI
CORONAVIRUS RNA TRANSCRIPTION--VIRUS-HOST INTERACTION$249,060
R01 · FY2002 · AI
CORONAVIRUS RNA TRANSCRIPTION--VIRUS-HOST INTERACTION$249,060
R01 · FY2001 · AI
CORONAVIRUS RNA TRANSCRIPTION--VIRUS-HOST INTERACTION$177,041
R01 · FY2000 · AI